Article

Poll: Were you warned about side effects?

Author(s):

Staff

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Image of woman with brown hair.
Image of man with black hair.
Image of bald man.
Image of man.
Image of Kumar.
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Image of Dr. Uboha.
Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.
Related Content
illustration of linda.
April 23rd 2025

The Burst of Spring: Reflection for Those Living with Cancer

Linda Cohen
As spring arrives, I embrace the season’s renewal, reflecting on my journey with cancer and the freedom I’ll feel when I stop my treatment. Life is a gift.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
FDA sign.
April 23rd 2025

FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor

Ryan Scott
The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
MATTHEW MANGOLD, B.S.N., RN, and ERIN LONGSTRETH, M.S.N., RN, OCN, NEA-BC
April 22nd 2025

Advocacy and ‘Radiating Valor’ Have a Transformative Impact

Erin Longstreth, M.S.N., RN, OCN, NEA-BC
On January 15, people gathered for the Air Matters: Radon & The Environment Community Education Event.
April 22nd 2025

Air Matters: Radon and the Environment

Lung Cancer Initiative (LCI)